Compare this test’s laboratory options
TBRF ImmunoBlot IgM
IGeneX1 test optionFrom $472.50
TBRF ImmunoBlot IgM
IGeneXCatalog information reviewed: August 24, 2026 by the Sunridge Medical clinical team.
What this laboratory test evaluates
The TBRF IgM ImmunoBlot Test is a qualitative immunoblot assay that detects IgM antibodies to four TBRF–associated Borrelia species. The IgM ImmunoBlot may be positive as early as 2 weeks after a tick bite and will usually remain positive for six to eight weeks after initial exposure.
Collection and processing
- Sample type: Serum
- Fasting: No
- Estimated laboratory processing: Results should arrive 10 business days after the lab receives samples.
How Sunridge uses laboratory information
Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.
Before requesting this test
Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.
Common questions about this laboratory test
- What sample does this test require?
- The listed sample type is Serum. Confirm current collection instructions in the approved order.
- Does this test require fasting?
- The current catalog record lists fasting as: No. Follow the instructions supplied with the approved order.
- How long does laboratory processing usually take?
- Results should arrive 10 business days after the lab receives samples.. Timing can change after collection or if a laboratory requires additional review.
About this test
The TBRF IgM ImmunoBlot Test is a qualitative immunoblot assay that detects IgM antibodies to four TBRF–associated Borrelia species. The IgM ImmunoBlot may be positive as early as 2 weeks after a tick bite and will usually remain positive for six to eight weeks after initial exposure.
Highlighted health areas
- Lyme & tick-borne disease
Biomarkers and report focus
The exact analytes and report format can change. Confirm the current contents in the Fullscript order before payment.
- RF Borrelia Genus IgM